Avexa's (ASX:AVX) anti-bacterial compound AVX13616 has performed well in lab tests conducted by licensee Valevia Pharmaceuticals. [ + ]

The Australian life science index is known for its volatility, but over the past decade it has outperformed the All Ordinaries and the Nasdaq by considerable margins. [ + ]

New research by Dr Mark Weiser of Tel Aviv University’s Sackler Faculty of Medicine and the Sheba Medical Center has revealed that ASD appears to share a root cause with other mental illnesses, including schizophrenia and bipolar disorder. [ + ]

Biota Holdings (ASX:BTA) has been cleared to merge with Nabi Biopharmaceuticals after shareholders in both companies approved the deal. [ + ]

A new study has helped solve the problem of how epigenetic information is passed from one generation of cells to the next. [ + ]

AusBiotech is pleased to announce that the bumper special edition of AusBiotech’s journal, Australasian Biotechnology, is now published, featuring a sneak peek at next week’s industry conference of the year, AusBiotech 2012, as well as a feature on tech transfer and biotechnology in Asia. [ + ]

Universal Biosensors (ASX:UBI) boosted its Q3 revenue by 50% and slashed its cash outflow, thanks to contributions from its two coagulation test strip partnerships. [ + ]

The Australian Academy of Science has commended the government’s commitment to maintain funding for science research through the Australian Research Council (ARC) and Cooperative Research Centres (CRCs). [ + ]

A team of researchers at The Australian National University is one step closer to better understanding how organisms function after discovering how epigenetic information is transmitted from one generation of cells to the next. [ + ]

Bioniche Life Sciences (ASX:BNC) has launched its first canine cancer product, Immunocidin, in the US and Canadian markets. [ + ]

Bluechiip (ASX:BCT) has partnered with Swiss laboratory systems developer Inpeco, agreeing to explore jointly developing Inpeco products with integrated Bluechiip tracking chips. [ + ]

WR Grace & Co announced today that the US Patent and Trademark Office has granted three additional notices of allowance related to the company’s Reveleris flash chromatography system. [ + ]

A University of Canterbury (UC) research project, in collaboration with the University of Otago, Christchurch (formerly known as Christchurch School of Medicine), has shown some promising signs in the treatment of ovarian cancer. [ + ]

There’s a new contender in the race to find an inexpensive alternative to platinum catalysts for use in hydrogen fuel cells - a graphene sheet covered by cobalt and cobalt-oxide nanoparticles. [ + ]

Allied Healthcare (ASX:AHZ) has reached a milestone with its CardioCel cardiovascular patch product, announcing its first surgical use outside of clinical trials. [ + ]